Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Az Alddien Natfji"'
Autor:
Gianfranco Pasut, Frances Beards, Francesca Greco, Abbie Dodd, Az Alddien Natfji, Antonella Grigoletto, Lewis Renshall, Lynda K. Harris, Helen M. I. Osborn, Angelos Evangelinos
Publikováno v:
Molecular Pharmaceutics. 19:345-353
Here, we evaluated the feasibility of non-prodrug PEG-drug conjugates to decrease the accumulation of drugs within the placental tissues. The results showed that PEG was biocompatible with the human placenta with no alteration of the basal rate of pr
Autor:
Helen M. I. Osborn, Az Alddien Natfji, Vitaliy V. Khutoryanskiy, Dmitry O. Nikitin, Kimberly A. Watson, Rouslan I. Moustafine, I. I. Semina, Gary J. Stephens, Francesca Greco, Hong Lin
We have previously reported the synthesis of a poly(ethylene glycol)-haloperidol (PEG-haloperidol) conjugate that retained affinity for its target D2 receptor and was stable in simulated physiological conditions. We hypothesised that this polymer-dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5a4821dc554e03e1428d3b1602017f8
Autor:
Shaban A. Khaled, Clive J. Roberts, Ricky D. Wildman, M. I. Evangelista Barreiros, Elizabeth A. Clark, Wayne Hayes, Az Alddien Natfji, Lewis R. Hart, Sara Salimi, Francesca Greco, Y. Wu
© 2020 The Royal Society of Chemistry. Using a novel molecular design approach, we have prepared a thermo-responsive supramolecular polyurethane as a matrix material for use in drug eluting implants. The dynamic supramolecular polyurethane (SPU) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::513c6a6eac724e0415baf9d69053ba8d
Publikováno v:
Current Opinion in Colloid & Interface Science. 31:51-66
Polymer-drug conjugates have been intensely studied in the context of improving cancer chemotherapy and yet the only polymer-drug conjugate on the market (Movantik®) has a different therapeutic application (relieving opioid-induced constipation). In
The enhanced permeability and retention (EPR) effect constitutes the rationale by which nanotechnologies selectively target drugs to tumors. Despite promising pre-clinical and clinical results, these technologies have, in our view, underachieved comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e21041b6652e5edd31e42751a02834b